Terms of Use & Privacy Policy - Clinical Trial Radar

Terms of Use

Please review the Clinical Trial Radar ("Trial Radar") Beta Participation Terms of Use.

Understanding ClinicalTrials.gov.

Trial Radar provides access to information about clinical trials primarily sourced from ClinicalTrials.gov, which is maintained by the National Library of Medicine (NLM). Please refer to these Terms and Conditions for use of ClinicalTrials.gov data.

Trial Radar does not modify data sourced from clinicaltrials.gov.
The U.S. government does not review or approve the safety and science of studies listed on ClinicalTrials.gov. Study sponsors or investigators are responsible for the safety, science, and accuracy of their listed studies.
ClinicalTrials.gov is an online database of clinical research studies, maintained by the NLM. It includes studies sponsored and funded by a range of public and private organizations globally. Not all studies are overseen or funded by U.S. government agencies.
Study information on ClinicalTrials.gov is provided by the sponsors or investigators. They are responsible for compliance with laws, regulations, and for providing accurate, complete information. NLM staff reviews submissions for apparent errors or inconsistencies.
Joining a study is a personal decision. Before participating, assess the risks and benefits and consult with healthcare professionals. Learn more about participating in clinical research studies by visiting the 'Learn About Studies' section on ClinicalTrials.gov.

Privacy Policy

This Privacy Policy outlines how the Clinical Trials Discovery Tool ("Trial Radar") safeguards user data. Operating under Investment Strategy, Inc., incorporated in Delaware and registered in California, Trial Radar is committed to protecting your privacy and complying with applicable data protection laws.

Your Data and Privacy

Data Collection and Use: Trial Radar does not collect or store personal health information. User inputs are utilized to provide general clinical trial information without linking to individual health records.
Generalized Clinical Trial Information: The tool offers non-personalized, general information about clinical trials.
Not a Medical Advice Substitute: Trial Radar is not a substitute for professional medical advice. Consult healthcare professionals for medical-related inquiries.
Legal Disclaimer: Users agree to not hold Trial Radar, its developers, or affiliates liable for any privacy breaches or claims arising from its use. The tool is offered "as is" without warranties, and usage is at your own risk.

User Anonymity and Data Security

While Trial Radar ensures user anonymity in general usage, the "Alerts" feature requires users to provide an email address to receive notifications. This section explains how we handle and protect your email information.

Email Collection for Alerts: For users opting into our "Alerts" service, an email address is necessary. This is the sole piece of personally identifiable information we collect for this specific feature.
Data Protection: We use the HS256 algorithm, a variant of the HMAC SHA-256 algorithm, for both encrypting and hashing your email address for secure storage. This ensures enhanced security and privacy, transforming your email into a unique and encrypted string that is unreadable and protected against unauthorized access.
Use of Email Information: The sole purpose of collecting your email is to send you alerts related to clinical trials. We do not use your email for any other marketing or promotional purposes, nor do we share it with third parties.
Opt-Out Option: You can opt out of the "Alerts" feature at any time. Upon opting out, your email address will be removed from our alerts system.

Legal Compliance and Updates

We regularly update our policy to remain compliant.

By using Trial Radar, you acknowledge and agree to these Terms and the Privacy Policy, and to the Terms and Conditions for use of ClinicalTrials.gov data. If you disagree, refrain from using the tool. Continued usage implies acceptance of any modifications. We encourage regular review of this policy for updates.